- $7.59bn
- $9.77bn
- $4.04bn
- 90
- 64
- 88
- 95
2019 December 28th | 2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,959 | 2,513 | 4,033 | 3,251 | 4,037 |
Cost of Revenue | |||||
Gross Profit | 1,103 | 882 | 1,447 | 1,195 | 1,534 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,445 | 2,189 | 3,393 | 2,621 | 3,402 |
Operating Profit | 514 | 324 | 640 | 630 | 635 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 463 | 268 | 564 | 620 | 519 |
Provision for Income Taxes | |||||
Net Income After Taxes | 352 | 207 | 437 | 488 | 401 |
Net Income Before Extraordinary Items | |||||
Net Income | 352 | 207 | 437 | 488 | 401 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 352 | 207 | 437 | 488 | 401 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.41 | 4.12 | 8.33 | 7.19 | 8.73 |